Yayın:
Activity of CDK4/6 inhibitors and parameters affecting survival in elderly patients in age-subgroups: Turkish Oncology Group (TOG) retrospective study

Sadeleştirilmiş öğe sayfası
dc.contributor.authorTurhal, N. S.
dc.contributor.authorMutlu Hızal
dc.contributor.authorBurçin Çakan Demirel
dc.contributor.authorDeniz Can Güven
dc.contributor.authorÖzge Gümüşay
dc.contributor.authorBaşak Oyan Uluç
dc.contributor.authorErtuğrul Bayram
dc.contributor.authorBurcu Gülbağcı
dc.contributor.authorAlper Yaşar
dc.contributor.authorSena Ece Davarcı
dc.contributor.authorEda Eylemer Mocan
dc.contributor.authorÖmer Acar
dc.contributor.authorDeniz Işık
dc.contributor.authorEsra Aydın
dc.contributor.authorYusuf Karakaş
dc.contributor.authorMelike Özçelik
dc.contributor.authorMurat Keser
dc.contributor.authorSadi Kerem Okutur
dc.contributor.authorÖnder Eren
dc.contributor.authorSerkan Menekşe
dc.contributor.authorDinçer Aydın
dc.contributor.authorFunda Yılmaz
dc.contributor.authorÖzlem Doğan
dc.contributor.authorGülhan Özkanlı
dc.contributor.authorHakan Yucel
dc.contributor.authorVeli Sunar
dc.contributor.authorMusa Barış Aykan
dc.contributor.authorÖzlem Özdemir
dc.contributor.authorBerna Bozkurt Duman
dc.contributor.authorMerve Keskinkılıç
dc.contributor.authorTeoman Şakalar
dc.contributor.authorAli̇ İnal
dc.contributor.authorMüge Karaoğlanoğlu
dc.contributor.authorAsude Aksoy
dc.contributor.authorMuhammed Muhiddin Er
dc.contributor.authorN. S. Turhal
dc.contributor.authorNurhan Önal Kalkan
dc.contributor.authorMehmet Alı Nahıt Şendur
dc.contributor.orcid0000-0002-5328-6554
dc.contributor.orcid0000-0001-5147-4431
dc.contributor.orcid0000-0003-0734-0692
dc.contributor.orcid0000-0002-6924-9467
dc.contributor.orcid0000-0002-6236-9829
dc.contributor.orcid0000-0002-6623-6273
dc.contributor.orcid0000-0001-8713-7613
dc.contributor.orcid0000-0002-5720-8254
dc.contributor.orcid0000-0001-8814-8947
dc.contributor.orcid0000-0003-0429-8142
dc.contributor.orcid0000-0002-6094-9264
dc.contributor.orcid0000-0003-0210-3153
dc.contributor.orcid0000-0003-0205-4590
dc.contributor.orcid0000-0003-0406-715X
dc.contributor.orcid0000-0003-1427-3774
dc.contributor.orcid0000-0002-2134-2128
dc.contributor.orcid0000-0003-3912-7191
dc.contributor.orcid0000-0003-4672-4621
dc.contributor.orcid0000-0001-7538-9119
dc.contributor.orcid0000-0003-2520-5953
dc.contributor.orcid0000-0002-3342-3144
dc.contributor.orcid0000-0003-2749-9414
dc.contributor.orcid0000-0002-0690-2529
dc.contributor.orcid0000-0002-5609-9658
dc.contributor.orcid0000-0002-0583-0295
dc.contributor.orcid0000-0002-1013-5676
dc.contributor.orcid0000-0002-2823-332X
dc.contributor.orcid0000-0001-7021-6139
dc.date.accessioned2025-11-13T10:30:06Z
dc.date.issued2024-12-30
dc.identifier.doihttps://doi.org/10.1186/s12885-024-13357-5
dc.identifier.endpage1592
dc.identifier.issn1471-2407
dc.identifier.issue1
dc.identifier.openalexW4405889989
dc.identifier.startpage1592
dc.identifier.urihttps://hdl.handle.net/11421/4348
dc.identifier.urihttps://doi.org/10.1186/s12885-024-13357-5
dc.identifier.volume24
dc.language.isoen
dc.relation.ispartofBMC Cancer
dc.rightsopenAccess
dc.subjectMedicine
dc.subjectInternal medicine
dc.subjectPalbociclib
dc.subjectNeutropenia
dc.subjectRetrospective cohort study
dc.subjectAdverse effect
dc.subjectSurgical oncology
dc.subjectStatistical significance
dc.subjectCohort
dc.subjectBreast cancer
dc.subjectOncology
dc.subjectCancer
dc.subjectMetastatic breast cancer
dc.subjectChemotherapy
dc.titleActivity of CDK4/6 inhibitors and parameters affecting survival in elderly patients in age-subgroups: Turkish Oncology Group (TOG) retrospective study
dc.typeArticle
dspace.entity.typePublication
local.authorid.openalexA5064011743

Dosyalar

Koleksiyonlar

Publications